Abecma Infusionsdispersion

Abecma Infusionsdispersion is a medicine authorised by Swissmedic under authorisation number 67575. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Transplant: gene therapy product and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 August 2021 and the authorisation is valid without a time limit. ATC code L01XL07 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 67575
  • ATC L01XL07
  • Transplant: gene therapy product
Authorisation data
Authorisation number67575
NameAbecma Infusionsdispersion
Full nameAbecma Infusionsdispersion, von 260 bis 500 × 10e6 CAR-positiven lebensfähigen T-Zellen
Authorisation holderBristol-Myers Squibb SA
Medicinal product codeTransplant: gene therapy product
Dispensing categoryA · Prescription, not repeatable
ATC codeL01XL07
First authorisation20 August 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Abecma Infusionsdispersion, von 260 bis 500 × 10e6 CAR-positiven lebensfähigen T-ZellenA20 August 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11 oder mehrereBeutelL01XL0707.16.4.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Abecma Infusionsdispersion authorised in Switzerland?

Yes. Abecma Infusionsdispersion is authorised by Swissmedic under authorisation number 67575, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Abecma Infusionsdispersion have?

Abecma Infusionsdispersion is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Abecma Infusionsdispersion?

The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com